Keith Speights writes for the Fools(which doesn't like Amrn) according to him Amrn 's management his doing a GREAT job in that regard getting Tier 2 where ever it can.
They will have a tough time starting the new drug in the market, (have they partnered yet) way too much competition etc.Time to make some bucks and get even.LOL
The company's pres should give us an idea where we stand with sales-refills and other equally important good news.In MHO the bubble is ready to burst.Any comment is welcome, besides the usual morons, that is.LOL
You are full of it, cut the crappola, buffoon !!!! B doesn't need BS because it does work and it's very well tolerated by users.and has multiple possible application being evaluated I'm waiting for more good news from Vegas this Friday. Stay tuned.
Who gives a shiet, really !!!! Nothing pertinent has been posted but BS.The truth is B has several different applications and that scares them even more,rightly so, I should add..